BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 1531306)

  • 21. Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC).
    Nagler A; Condiotti R; Rabinowitz R; Schlesinger M; Nguyen M; Terstappen LW
    Med Oncol; 1999 Sep; 16(3):177-87. PubMed ID: 10523797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow.
    Selvaggi KJ; Wilson JW; Mills LE; Cornwell GG; Hurd D; Dodge W; Gingrich R; Martin SE; McMillan R; Miller W
    Blood; 1994 Mar; 83(6):1698-705. PubMed ID: 8123862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: long-term follow-up.
    Mehta J; Powles R; Treleaven J; Horton C; Shepherd V; Hale G; Waldmann H; Singhal S
    Leuk Lymphoma; 1997 May; 25(5-6):479-86. PubMed ID: 9250818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
    Nimgaonkar M; Kemp A; Lancia J; Ball ED
    J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging.
    Billett AL; Sallan SE
    Am J Pediatr Hematol Oncol; 1993 May; 15(2):162-8. PubMed ID: 8498641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia.
    Bradstock KF; Stevens M; Bergin M; Dalla-Pozza L; Duval P; Favaloro EJ; Kabral A; Kerr A; Juttner C; Zola H
    Aust N Z J Med; 1987 Jun; 17(3):283-9. PubMed ID: 2960307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry.
    Farahat N; Morilla A; Owusu-Ankomah K; Morilla R; Pinkerton CR; Treleaven JG; Matutes E; Powles RL; Catovsky D
    Br J Haematol; 1998 Apr; 101(1):158-64. PubMed ID: 9576196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
    Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
    J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukemia diagnosis and testing of complement-fixing antibodies for bone marrow purging in acute lymphoid leukemia.
    Campana D; Janossy G
    Blood; 1986 Dec; 68(6):1264-71. PubMed ID: 3535926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
    Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
    Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purging with 4-hydroperoxycyclophosphamide.
    Jones RJ
    J Hematother; 1992; 1(4):343-8. PubMed ID: 1345676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
    Rowley SD; Jones RJ; Piantadosi S; Braine HG; Colvin OM; Davis J; Saral R; Sharkis S; Wingard J; Yeager AM
    Blood; 1989 Jul; 74(1):501-6. PubMed ID: 2665843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.
    Gonzales-Chambers R; Przepiorka D; Shadduck RK; Borochovitz D; Bloom EJ; Colvin OM; Mangan KF; Rosenfeld CS
    Med Pediatr Oncol; 1991; 19(3):160-4. PubMed ID: 2023563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autologous BMT for B-lineage adult ALL patients using ex vivo purging with monoclonal antibodies].
    Mizuta S; Kawano A
    Rinsho Ketsueki; 1997 May; 38(5):422-5. PubMed ID: 9194387
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure.
    Ito T; Ishikawa Y; Noda M; Fujii R
    Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations.
    Negrin RS; Pesando J
    J Clin Oncol; 1994 May; 12(5):1021-7. PubMed ID: 8164025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.